Treatment Options for Low Testosterone Levels
Testosterone replacement therapy (TRT) is recommended for men with consistently low testosterone levels (<300 ng/dL on at least two early morning measurements) who exhibit symptoms of hypogonadism to improve quality of life and reduce morbidity. 1
Diagnosis Criteria
- Definition of low testosterone: Total testosterone levels <300 ng/dL measured on at least two separate early morning occasions 1
- Symptoms requiring evaluation:
- Reduced energy and endurance
- Diminished work/physical performance
- Fatigue
- Depression and reduced motivation
- Poor concentration and impaired memory
- Irritability
- Reduced sex drive
- Changes in erectile function
- Infertility 1
Treatment Options
1. Testosterone Formulations
Topical gels (1.62%):
Oral testosterone undecanoate:
- Initial dose: 200 mg orally twice daily
- Can be titrated to 100-400 mg based on response 3
- Newer option with convenient oral administration
Injectable testosterone:
2. Lifestyle Modifications
- Weight management
- Regular exercise
- Mediterranean diet (emphasizing fruits, vegetables, beans, whole grains, nuts, fish)
- Moderate alcohol consumption (<21 units/week) 4, 1
Monitoring Protocol
Initial monitoring (3-6 months):
- Testosterone levels (target: 450-600 ng/dL)
- Hematocrit (discontinue if >54%)
- PSA
- Symptom response 1
Long-term monitoring (annually):
- Testosterone levels
- Hematocrit
- PSA (in men ≥40 years)
- Symptom evaluation 1
Benefits of TRT
- Improved sexual function
- Enhanced sense of well-being
- Increased lean body mass
- Decreased body fat
- Increased bone density 1
- Potential improvement in insulin sensitivity and glycemic control in men with metabolic syndrome 4
Risks and Contraindications
Contraindications:
- Breast or prostate cancer
- Hematocrit >50%
- Severe untreated sleep apnea
- Severe lower urinary tract symptoms
- Uncontrolled heart failure
- Current or future fertility desires (with traditional TRT) 1
Potential adverse effects:
- Increased hematocrit (polycythemia)
- Potential cardiovascular risks (FDA warning about possible increased risk of heart attack and stroke) 1, 2
- Worsening of benign prostatic hyperplasia symptoms
- Edema
- Gynecomastia
- Suppression of spermatogenesis 3
Special Considerations
- Men desiring fertility: Consider alternative treatments such as clomiphene citrate or exogenous gonadotropins rather than traditional TRT 5
- Recent cardiovascular events: Delay TRT for 3-6 months 1
- Secondary exposure risk: Strict adherence to application instructions for topical formulations to prevent transfer to women and children 2
Treatment Algorithm
- Confirm diagnosis: Two morning testosterone measurements <300 ng/dL + symptoms
- Rule out contraindications
- Select appropriate formulation based on:
- Patient preference
- Cost considerations (injectable more affordable)
- Fertility concerns (avoid traditional TRT if fertility desired)
- Initiate treatment at recommended starting dose
- Monitor response at 3-6 months and adjust dose as needed
- Continue long-term monitoring annually
TRT should be considered a long-term therapy, as discontinuation typically results in return to hypogonadal state within 6 months 6.